5-132387134-A-G

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_003060.4(SLC22A5):​c.934A>G​(p.Ile312Val) variant causes a missense change. The variant allele was found at a frequency of 0.00148 in 1,614,112 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0011 ( 0 hom., cov: 32)
Exomes š‘“: 0.0015 ( 3 hom. )

Consequence

SLC22A5
NM_003060.4 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:6

Conservation

PhyloP100: 4.04
Variant links:
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.017567307).
BP6
Variant 5-132387134-A-G is Benign according to our data. Variant chr5-132387134-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 381879.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=4, Uncertain_significance=3}.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC22A5NM_003060.4 linkc.934A>G p.Ile312Val missense_variant Exon 5 of 10 ENST00000245407.8 NP_003051.1 O76082-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC22A5ENST00000245407.8 linkc.934A>G p.Ile312Val missense_variant Exon 5 of 10 1 NM_003060.4 ENSP00000245407.3 O76082-1

Frequencies

GnomAD3 genomes
AF:
0.00107
AC:
163
AN:
152130
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000377
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00207
Gnomad OTH
AF:
0.000958
GnomAD3 exomes
AF:
0.000851
AC:
214
AN:
251494
Hom.:
0
AF XY:
0.000839
AC XY:
114
AN XY:
135922
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000653
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00165
Gnomad OTH exome
AF:
0.000814
GnomAD4 exome
AF:
0.00152
AC:
2228
AN:
1461864
Hom.:
3
Cov.:
32
AF XY:
0.00152
AC XY:
1106
AN XY:
727226
show subpopulations
Gnomad4 AFR exome
AF:
0.000358
Gnomad4 AMR exome
AF:
0.000380
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.0000562
Gnomad4 NFE exome
AF:
0.00188
Gnomad4 OTH exome
AF:
0.00179
GnomAD4 genome
AF:
0.00106
AC:
162
AN:
152248
Hom.:
0
Cov.:
32
AF XY:
0.000927
AC XY:
69
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.000217
Gnomad4 AMR
AF:
0.000392
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.000377
Gnomad4 NFE
AF:
0.00206
Gnomad4 OTH
AF:
0.000948
Alfa
AF:
0.00144
Hom.:
1
Bravo
AF:
0.000960
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00186
AC:
16
ExAC
AF:
0.000807
AC:
98
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00153
EpiControl
AF:
0.00196

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 14, 2021
GeneDx
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 20574985, 18337137, 28841266) -

Jul 01, 2020
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Renal carnitine transport defect Uncertain:1Benign:3
Jul 15, 2021
Genome-Nilou Lab
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Oct 03, 2022
Giacomini Lab, University of California, San Francisco
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: in vitro;research

- -

not specified Uncertain:1
May 09, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: SLC22A5 c.934A>G (p.Ile312Val) results in a conservative amino acid change located in the major facilitator superfamily domain (IPR020846) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.00085 in 251494 control chromosomes, predominantly at a frequency of 0.0017 within the Non-Finnish European subpopulation in the gnomAD database. This frequency is not significantly higher than estimated for a pathogenic variant in SLC22A5 causing Systemic Primary Carnitine Deficiency (0.00085 vs 0.0046), allowing no conclusion about variant significance. c.934A>G has been reported in the literature as a VUS in the heterozygous state in individuals with cardiomyopathy suspected of Systemic Primary Carnitine Deficiency and as an uninformative genotype (i.e. zygosity not specified) in a case of sudden unexplained death (e.g. Amat di San Filippo_2008, Li_2010, Christiansen_2016). These reports do not provide unequivocal conclusions about association of the variant with Systemic Primary Carnitine Deficiency. Publications reporting experimental evidence evaluating an impact on protein function found that the variant has little impact on carnitine transport, maintaining above 65% of WT activity (e.g. Amat di San Filippo_2008, Frigeni_2017). The following publications have been ascertained in the context of this evaluation (PMID: 18337137, 27650965, 28841266, 20574985). Six submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as either likely benign (n=4) or VUS (n=2). Based on the evidence outlined above, the variant was classified as VUS-possibly benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.31
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.16
T;.;.
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.35
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.72
T;T;T
M_CAP
Benign
0.042
D
MetaRNN
Benign
0.018
T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.3
L;.;.
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.91
N;N;N
REVEL
Benign
0.12
Sift
Benign
0.042
D;D;T
Sift4G
Benign
0.31
T;T;T
Polyphen
0.051
B;.;.
Vest4
0.28
MVP
0.56
MPC
0.19
ClinPred
0.025
T
GERP RS
1.3
Varity_R
0.19
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77300588; hg19: chr5-131722826; COSMIC: COSV55375386; COSMIC: COSV55375386; API